Drawing for COLVERA

USPTO serial 87112716

COLVERA

Reviewed by CopyMark Law Group

Reg. 5304460Status 702Renewal
Filing date
Status date
Registration date
Oct 10, 2017
Examiner
SANDER, DREW M
Law office
TMO LAW OFFICE 110

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with COLVERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sarah W. Matthews

Sarah W. Matthews Dentons Durham Jones Pinegar3301 N Thanksgiving Way, Suite 400Lehi, UT 84043UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for the withdrawal of blood for medical test purposes; Apparatus for blood analysis; Blood testing apparatus; Apparatus for carrying-out medical diagnostic tests for testing blood for the presence of genes associated with cancer; medical apparatus for use in blood test procedures; Medical diagnostic apparatus in kit form for testing blood for the presence of genes associated with cancer; Medical apparatus for use in in-vitro diagnosis of blood; Diagnostic apparatus for medical purposes for the detection of cancer; Medical diagnostic testing apparatus for testing blood for the presence of genes associated with cancer; Scientific apparatus for use in medical diagnostic applications, namely, for use in diagnosing cancer; Blood testing medical apparatus in kit form; Medical diagnostic instruments for testing blood for the presence of genes associated with cancer; Medical diagnostic instruments for the analysis of body fluids; Tools for medical diagnosis, namely, medical diagnostic apparatus for testing blood for the presence of genes associated with cancer; Instruments for medical diagnosis namely, medical diagnostic apparatus for testing blood for the presence of genes associated with cancerACTIVE—
042Scientific laboratory services; Technical diagnostic testing services in the field of medical diagnostic equipment; Medical laboratory testing services; Medical research; Research and development of new products; Laboratory research in the field of genetics; Scientific research relating to molecular sciences; Scientific research; Scientific research into the development of new products; Scientific research relating to genetics; Providing advice in the field of technical diagnostic products; Biotechnology, research, namely, testing; DNA analysis services, namely, testing for scientific research purposes; Development of diagnostic test equipment; conducting clinical trials for othersACTIVE—
044Medical diagnostic services, namely, testing and analysis in the field of genetics and cancer; Medical health assessment services; Medical screening; Medical services; Provision of medical information; Medical advisory services relating to diseases; Medical advisory services relating to health; Health care; Health screening in the field of cancer; Services for the testing of blood; medical services in the field of pathologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 15, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 15, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 14, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 16, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Oct 10, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 10, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 17, 2017ALIEASSIGNED TO LIE—
Apr 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 3, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 3, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 2, 2016DOCKASSIGNED TO EXAMINER—
Jul 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 26, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance